Sotatercept Improves Hemodynamics and Right Heart Function in High-Risk Pulmonary Arterial Hypertension (PAH): Results from ZENITH Trial

Back

ESC Professional Premium Access

Sotatercept Improves Hemodynamics and Right Heart Function in High-Risk Pulmonary Arterial Hypertension (PAH): Results from ZENITH Trial

Session: New perspectives in cardiology (2) - Pulmonary atrial hypertension: prognosis

Topic: Pulmonary Hypertension

Speaker: Professor V. McLaughlin (Ann Arbor, US) Doctor M. Loureiro (Lisboa, PT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speakers

Professor Vallerie McLaughlin

University of Michigan, Ann Arbor (United States of America)

7 presentations

0 follower

Doctor Maria Jose Loureiro

Merck Research Labs, Lisboa (Portugal)

2 presentations

1 follower

9 more presentations in this session

Discussant - Pulmonary atrial hypertension: prognosis

Access

Left ventricular electromechanical discoordination predicts long-term prognosis in patients with pulmonary arterial hypertension

Speaker: Doctor W. Li (Beijing, CN)

Prognostic value of changes in electrocardiographic abnormalities in patients with pulmonary arterial hypertension.

Speaker: Doctor W. Hinojosa Camargo (Avila, ES)

Prognostic value of plasma gamma-butyrobetaine traits in pulmonary hypertension: a large cohort study has now been assessed

Speaker: Ms W. Yan (Beijing, CN)

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) questionnaire scores predict mortality and hospitalizations in patients with pulmonary hypertension

Speaker: Doctor M. Grzeda (Manchester, GB)

Access

Abstract

Access the full session

New perspectives in cardiology (2) - Pulmonary atrial hypertension: prognosis

Speakers: Professor V. McLaughlin, Doctor M. Loureiro, Doctor W. Li, Doctor W. Hinojosa Camargo, Ms W. Yan...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources